ResMed Inc

Healthcare · Medical Instruments & Supplies

223.60$ -0.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

ResMed Inc (RMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 5,653 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RMD
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	49	67	89	116	155	204	274	339	426	607	716	835	921	1,092	1,243	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146	5,653
Cost of Revenue	18	19	25	31	50	71	100	123	151	230	332	342	367	437	502	548	574	565	668	772	865	978	1,070	1,239	1,358	1,554	1,867	2,030	2,091	2,196
Gross Profit	32	47	64	85	105	133	173	217	275	377	384	494	554	655	741	821	941	990	1,011	1,066	1,202	1,362	1,537	1,718	1,839	2,024	2,356	2,655	3,055	3,458
Research & Development	3.8	5.0	6.5	8.5	11	15	21	26	30	37	50	61	63	75	92	110	120	118	115	119	144	155	181	202	225	254	288	308	331	378
Selling, General & Administrative	17	21	27	37	50	64	85	105	136	200	237	278	290	332	372	402	431	450	479	488	554	600	645	677	670	739	874	917	991	1,120
Total Operating Expenses	23	30	39	52	79	184	106	131	166	244	294	348	363	412	473	525	586	585	602	625	776	820	957	909	935	1,024	1,224	1,335	1,370	1,565
Operating Income	8.3	17	25	33	26	-51	67	85	97	131	90	143	190	240	267	294	355	405	409	429	426	542	579	810	904	1,000	1,132	1,320	1,685	1,893
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	1.3	1.3	10	10	10	1.8	4.8	6.4	6.1	5.8	11	28	28	36	40	24	22	47	46	13	29
Pre-Tax Income	11	16	25	34	27	55	67	85	97	133	98	158	202	261	304	332	385	431	436	440	419	521	519	733	884	960	1,102	1,265	1,678	1,919
Income Tax Expense	3.6	5.5	8.5	12	16	17	21	27	32	45	32	48	55	71	77	77	78	86	83	87	76	206	114	111	409	181	204	244	277	396
Net Income	7.5	11	16	22	12	38	46	57	65	88	66	110	146	190	227	255	307	345	353	352	342	316	405	622	475	779	898	1,021	1,401	1,523
EBITDA	11	21	30	39	52	-41	80	85	137	174	90	205	190	322	374	423	470	485	482	541	569	680	706	990	1,104	1,177	1,359	1,534	1,913	2,146

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings